Review: Diabetes is not a coronary disease equivalent

Farkouh, Michael E.; Idris, I.
August 2009
ACP Journal Club;8/18/2009, Vol. 151 Issue 2, p4
Academic Journal
The article reports that patients with diabetes and no history of myocardial infarction (MI) have a lower risk for coronary artery disease (CAD) events than patients with previous MI and no diabetes. Included studies compared risk for CAD events in patients with diabetes and no MI and patients with previous MI and no diabetes. Therefore, experts have argued that patients with diabetes and no coronary events should be treated in a similar fashion to their counterparts with CAD.


Related Articles

  • Relationship Between Glycosylated Hemoglobin Assessment and Glucose Therapy Intensification in Patients With Diabetes Hospitalized for Acute Myocardial Infarction. Stolker, Joshua M.; Spertus, John A.; McGuire, Darren K.; Lind, Marcus; Tang, Fengming; Jones, Philip G.; Inzucchi, Silvio E.; Rathore, Saif S.; Maddox, Thomas M.; Masoudi, Frederick A.; Kosiborod, Mikhail // Diabetes Care;May2012, Vol. 35 Issue 5, p991 

    OBJECTIVE--To evaluate the relationship between A1C and glucose therapy intensification (GTI) in patients with diabetes mellitus (DM) hospitalized for acute myocardial infarction (AMI). RESEARCH DESIGN AND METHODSdA1C was measured as part of routine care (clinical A1C) or in the core laboratory...

  • Record linked retrospective cohort study of 4.6 million people exploring ethnic variations in disease: myocardial infarction in South Asians. Fischbacher, C. M.; Bhopal, R.; Povey, C.; Steiner, M.; Chalmers, J.; Mueller, G.; Jamieson, J.; Knowles, D. // BMC Public Health;2007, Vol. 7, p142 

    Background: Law and policy in several countries require health services to demonstrate that they are promoting racial/ethnic equality. However, suitable and accurate data are usually not available. We demonstrated, using acute myocardial infarction, that linkage techniques can be...

  • Risk and potential risk reduction in diabetes type 2 patients in Germany. Häussler, Bertram; Berger, Ursula; Mast, Oliver; Thefeld, Wolfgang // European Journal of Health Economics;Jun2005, Vol. 6 Issue 2, p152 

    Avoiding serious complications such as stroke, myocardial infarction, and amputations in diabetes patients is the main interest of long-term treatment. Given the considerable prevalence of diabetes type 2 in industrialized countries this is a major public health concern as well as a burden to...

  • Hyperglycemia can delay left ventricular dysfunction but not autonomic damage after myocardial infarction in rodents. Rodrigues, Bruno; Rosa, Kaleizu T.; Medeiros, Alessandra; Schaan, Beatriz D.; Brum, Patricia C.; De Angelis, Kátia; Irigoyen, and Maria Cláudia // Cardiovascular Diabetology;2011, Vol. 10 Issue 1, p26 

    Background: Although clinical diabetes mellitus is obviously a high risk factor for myocardial infarction (MI), in experimental studies disagreement exists about the sensitivity to ischemic injury of an infarcted myocardium. Recently, our group demonstrated that diabetic animals presented better...


    The article discusses a study evaluating how prandial and basal control of type 2 diabetes after a myocardial infarction affects the risk of cardiac events. The study was published in the March issue of "Diabetes Care." The group given insulin before meals had lower postprandial blood sugar. The...

  • Fasting Plasma Glucose Predicts Survival And Angiographic Progression in High-Risk Postmenopausal Women with Coronary Artery Disease. Vaidya, Dhananjay; Kelemen, Mark D.; Bittner, Vera; Tardif, Jean-Claude; Thompson, Paul; Ouyang, Pamela // Journal of Women's Health (15409996);Mar2007, Vol. 16 Issue 2, p228 

    Background: We studied the association of baseline fasting plasma glucose (FPG) levels with survival and coronary artery disease (CAD) progression among postmenopausal women without unstable angina. Methods: Women were recruited from seven centers in the Women's Angiographic Vitamin and Estrogen...

  • COMMENTARY: Review: Pioglitazone does not reduce risk for mortality or cardivascular events in type 2 diabetes. Smith, Donald // ACP Journal Club;Mar/Apr2007, Vol. 146 Issue 2, p40 

    The article presents the author's views about a study which states that pioglitazone does not reduce risk for mortality or cardivascular events in type 2 diabetes. The study lasted for 35 months and included patients with diabetes and macrovascular disease at baseline. Pioglitazone did not lower...

  • Vitamin D deficiency linked to CV risk in black people. Moberly, Tom // GP: General Practitioner;1/15/2010, p12 

    The article offers information on a research conducted by Kevin Fiscella and colleagues from the University of Rochester which has revealed that low vitamin D levels increase heart attack risk and may account for higher cardiovascular risk among black people. The researchers further said that...

  • Screening does not cut cardiac risk for diabetics.  // GP: General Practitioner;4/17/2009, p3 

    The article reports on a research of screening for coronary artery disease (CAD) in patients with type-2 diabetes. According to the study, the screening does not reduce the rate of heart attacks or the number of cardiac deaths. Researchers also found further doubt over the effectiveness of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics